Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure

Clinical trial NCT00026169 · COMPLETED

Trial details

NCT number: NCT00026169
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2001-09-01
Primary completion: 2005-04-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.